2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1285637553 M.D.
Verify on CMS →

JESUS PENABAD, M.D.

Endocrinology, Diabetes & Metabolism Physician in HUDSON, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
7K
Medicare Part D claims · 768 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
54%
generic claims · 46% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
93.471/100
▲ 10 pts above national avg 83.1 · [object Object]
Industry payments
$1.9K
86 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JESUS PENABAD, M.D. reported a CMS MIPS final score of 93.471/100 — above the 83.1 national average — and filed 6,886 Medicare Part D claims in 2023.

93.471/100
MIPS score · +10 vs avg
7K
Part D claims, 2023
54%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JESUS PENABAD, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

93 Top 29% higher than 71% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

JESUS PENABAD, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JESUS PENABAD, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 05/31/2005

NPI 1285637553

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

6,886 161% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

93.471/100 10.37100000000001% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Florida

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers

Florida providers

Endocrinology, Diabetes & Metabolism Physician share within Florida

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Florida

Medicare quality performance — MIPS

JESUS PENABAD, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

High performer (top quartile)
MIPS Final Score
93.471/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 93.471/100 vs national avg 83.1

0%100%National avg83%93.5%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 93.471/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JESUS PENABAD, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 14100 FIVAY RD, HUDSON, FL, 34667, with a listed phone of (727) 869-7822. NPI 1285637553 was issued on 05/31/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PENABAD most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 6,886 prescription claims written by this provider, covering 768 Medicare beneficiaries and totaling roughly $4.4 million in drug spend, split 46% brand-name and 54% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93.471/100 for the 2023 performance year (Quality 85.0381), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

14100 FIVAY RD
HUDSON, FL 34667

Provider Details

NPI 1285637553
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Male
NPI Issued 05/31/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

93.471
Final Score
Avg: 83.1
85.0381
Quality
89
Promoting Interoperability

Reporting: Individual

Hospital and facility affiliations

Facilities where JESUS PENABAD, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

DIABETES CARE CENTER, INC
CLEARWATER, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JESUS PENABAD, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.9K

Largest payer

SANOFI-AVENTIS U.S. LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to JESUS PENABAD, M.D.. To verify JESUS PENABAD, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

JESUS PENABAD, M.D. — brand share 46.0%
Specialty average (est.)

46% brand-name claims vs 54% generic, on 6,886 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

6,886
Total Claims
$4.4M
Total Drug Cost
768
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
16,033
Total Day Supply
476,567
Brand vs Generic
46% brand / 54% generic
Brand Drug Cost
$4.1M
Generic Drug Cost
$100K

Patient Demographics

Average Patient Age
73.2 years
Avg HCC Risk Score
2.00
Gender Split
57% female / 43% male
Age Distribution
<65: 92, 65-74: 327, 75-84: 264, 85+: 85

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JESUS PENABAD, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
634
Metformin Hcl
399
Atorvastatin Calcium
380
Ozempic
Semaglutide
371
Jardiance
Empagliflozin
306
Tresiba Flextouch U-100
Insulin Degludec
255
Rosuvastatin Calcium
238
Novolog Flexpen
Insulin Aspart
217
Ezetimibe
199
Glimepiride
182

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How JESUS PENABAD, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

JESUS PENABAD, M.D.'s 6,886 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as PENABAD.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JESUS PENABAD, M.D.'s specialty?
JESUS PENABAD, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in HUDSON, Florida. Credentials: M.D..
How much does JESUS PENABAD, M.D. prescribe under Medicare Part D?
In 2023, JESUS PENABAD, M.D. wrote 6,886 Medicare Part D claims totaling $4.4M in drug costs for 768 beneficiaries.
What is JESUS PENABAD, M.D.'s Medicare quality score?
JESUS PENABAD, M.D. has a CMS MIPS Final Score of 93.471/100 (Quality: 85.0381). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JESUS PENABAD, M.D. located?
JESUS PENABAD, M.D. is located at 14100 FIVAY RD, HUDSON, FL, 34667. Phone: (727) 869-7822.
What is JESUS PENABAD, M.D.'s NPI number?
JESUS PENABAD, M.D.'s National Provider Identifier (NPI) is 1285637553, issued on 05/31/2005.
Does JESUS PENABAD, M.D. prescribe more brand-name or generic drugs?
JESUS PENABAD, M.D.'s prescribing is 46% brand-name and 54% generic drugs by claim count, with $4.1M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does JESUS PENABAD, M.D. prescribe most often?
Based on 2023 Medicare Part D data, JESUS PENABAD, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JESUS PENABAD, M.D. accept Medicare?
JESUS PENABAD, M.D. appears in CMS Medicare data with 6,886 Part D claims and 768 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JESUS PENABAD, M.D.'s credentials?
JESUS PENABAD, M.D.'s NPI is 1285637553 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology